Search / Trial NCT06615713

Evaluate the Safety and Effectiveness of Steerable Ureteroscopic Renal Evacuation (SURE) Using the CVAC® System

Launched by CALYXO, INC. · Sep 24, 2024

Trial Information

Current as of December 21, 2024

Active, not recruiting

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Candidate for ureteroscopy with laser lithotripsy;
  • Be willing and able to return for and respond to all study-related follow up procedures; and,
  • Have been informed of the nature of the study and have agreed to the IRB approved informed consent form (ICF).
  • Exclusion Criteria:
  • Significant morbidities;
  • Unable to meet the treatment and follow up protocol requirements; and,
  • Ureteral or kidney abnormalities.

About Calyxo, Inc.

Calyxo, Inc. is a biopharmaceutical company dedicated to advancing innovative therapies for the treatment of complex diseases. With a focus on harnessing cutting-edge research and development, Calyxo aims to improve patient outcomes through its commitment to scientific excellence and rigorous clinical trials. The company prioritizes collaboration with healthcare professionals and stakeholders to ensure that its therapeutic solutions address unmet medical needs effectively. Through its pipeline of promising candidates, Calyxo, Inc. strives to contribute to the future of medicine by transforming scientific discoveries into tangible health solutions.

Locations

Nadiad, , India

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0